Mpro/PLPro-IN-2 (Compound 22l) is a non-covalent competitive dual inhibitor of SARS-CoV-2s papain-like protease and main protease, exhibiting a Ki of 0.2 µM for the papain-like protease and 1.1 µM for the main protease. Mpro/PLPro-IN-2 is applicable in research related to anti-SARS-CoV-2 efforts.
Target-Kategorie:
SARS-CoV|||Virus Protease
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
